Astellas Pharma Inc (ALPMY)
9.585
+0.04
(+0.47%)
USD |
OTCM |
Apr 26, 10:08
Astellas Pharma Cash from Operations (TTM): 1.603B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.603B |
September 30, 2023 | 1.755B |
June 30, 2023 | 2.139B |
March 31, 2023 | 2.427B |
December 31, 2022 | 1.961B |
September 30, 2022 | 2.039B |
June 30, 2022 | 2.304B |
March 31, 2022 | 2.293B |
December 31, 2021 | 2.576B |
September 30, 2021 | 3.078B |
June 30, 2021 | 3.060B |
March 31, 2021 | 2.895B |
December 31, 2020 | 2.632B |
September 30, 2020 | 2.178B |
June 30, 2020 | 2.176B |
March 31, 2020 | 2.043B |
December 31, 2019 | 2.092B |
September 30, 2019 | 2.275B |
June 30, 2019 | 2.059B |
March 31, 2019 | 2.333B |
December 31, 2018 | 2.721B |
September 30, 2018 | 2.788B |
June 30, 2018 | 2.627B |
March 31, 2018 | 2.821B |
December 31, 2017 | 2.377B |
Date | Value |
---|---|
September 30, 2017 | 2.338B |
June 30, 2017 | 2.546B |
March 31, 2017 | 2.179B |
December 31, 2016 | 2.885B |
September 30, 2016 | 2.717B |
June 30, 2016 | 2.538B |
March 31, 2016 | 2.614B |
December 31, 2015 | 1.803B |
September 30, 2015 | 1.533B |
June 30, 2015 | 1.367B |
March 31, 2015 | 1.716B |
December 31, 2014 | 1.860B |
September 30, 2014 | 2.173B |
June 30, 2014 | 2.270B |
March 31, 2014 | 2.139B |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
1.603B
Minimum
Dec 2023
3.078B
Maximum
Sep 2021
2.294B
Average
2.178B
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Takeda Pharmaceutical Co Ltd | 5.353B |
Nxera Pharma Co Ltd | -37.58M |
PeptiDream Inc | 88.53M |
Stemcell Holdings Inc | 2.544M |
Healios KK | -20.11M |